Wilbanks Smith & Thomas Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,767
| Closed | -$348K | – | 539 |
|
|
2023
Q3 | $348K | Buy |
+4,767
| New | +$348K | 0.01% | 374 |
|
|
2023
Q2 | – | Sell |
-2,887
| Closed | -$220K | – | 534 |
|
|
2023
Q1 | $220K | Hold |
2,887
| – | – | 0.01% | 471 |
|
|
2022
Q4 | $240K | Sell |
2,887
-319
| -10% | -$26.5K | 0.01% | 431 |
|
|
2022
Q3 | $254K | Sell |
3,206
-76
| -2% | -$6.02K | 0.01% | 396 |
|
|
2022
Q2 | $244K | Buy |
+3,282
| New | +$244K | 0.01% | 416 |
|
|
2018
Q4 | – | Sell |
-50
| Closed | -$5K | – | 1320 |
|
|
2018
Q3 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 1241 |
|